Researchers and UF Innovate | Accelerate startup founders find Highly Effective Therapeutic Strategy for Small-Cell Lung Cancer
The proteins BCL-XL and BCL-2 can be targeted to help treat small-cell lung cancer (SCLC), a team of researchers has found. Previous treatments targeted these proteins using navitoclax, an anti-cancer drug, which resulted in platelet toxicity.